[Federal Register Volume 80, Number 203 (Wednesday, October 21, 2015)]
[Notices]
[Pages 63791-63792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-26757]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting: Advisory Board on Radiation and Worker Health (ABRWH or 
Advisory Board), National Institute for Occupational Safety and Health 
(NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), 
announces the following meeting of the aforementioned committee:
    Times and Dates: 8:15 a.m.-5 p.m., Pacific Time, November 18, 2015. 
8:15 a.m.-4:30 p.m., Pacific Time, November 19, 2015.
    Public Comment Time and Date: 5 p.m.-6 p.m.*, Pacific Time, 
November 18, 2015.
    * Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever is 
earlier. Members of the public who wish to provide public comments 
should plan to attend the public comment session at the start time 
listed.
    Place: Waterfront Hotel, 10 Washington Street, Oakland, California 
94607, Phone: 510-379-2652; Fax: 510-832-6228. Audio Conference Call 
via FTS Conferencing. The USA toll-free, dial-in number is 1-866-659-
0537 with a pass code of 9933701. Live Meeting CONNECTION: https://www.livemeeting.com/cc/cdc/join?id GS59T7&role=attend&pw=ABRWH; Meeting 
ID: GS59T7; Entry Code: ABRWH.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 100 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines which have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule; advice on methods of dose reconstruction which have 
also been promulgated by HHS as a final rule; advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program; and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2017.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advising the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters For Discussion: The agenda for the Advisory Board meeting

[[Page 63792]]

includes: NIOSH Program Update; Department of Labor Program Update; 
Department of Energy Program Update; Report by the Dose Reconstruction 
Review Methods Work Group; SEC Petitions Update; Site Profile reviews 
for: Dow Chemical Co. (Madison, Illinois), and General Steel Industries 
(Granite City, Illinois); SEC petitions for: Battelle Laboratories, 
King Avenue (1956-1970; Columbus, Ohio), Lawrence Livermore National 
Laboratory (1974-1995; Livermore, California), Blockson Chemical Co. 
(1960-1991; Joliet, Illinois), Rocky Flats Plant (1984-1989; Golden, 
Colorado), Idaho National Laboratory (1949-1970; Scoville, Idaho), and 
Kansas City Plant (1949-1993; Kansas City, Missouri); and Board Work 
Sessions.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be 
submitted to the contact person well in advance of the meeting. Any 
written comments received will be provided at the meeting in accordance 
with the redaction policy provided below.
    Policy on Redaction of Board Meeting Transcripts (Public Comment): 
(1) If a person making a comment gives his or her personal information, 
no attempt will be made to redact the name; however, NIOSH will redact 
other personally identifiable information, such as contact information, 
social security numbers, case numbers, etc., of the commenter.
    (2) If an individual in making a statement reveals personal 
information (e.g., medical or employment information) about themselves 
that information will not usually be redacted. The NIOSH Freedom of 
Information Act (FOIA) coordinator will, however, review such 
revelations in accordance with the Federal Advisory Committee Act and 
if deemed appropriate, will redact such information.
    (3) If a commenter reveals personal information concerning a living 
third party, that information will be reviewed by the NIOSH FOIA 
coordinator, and upon determination, if deemed appropriated, such 
information will be redacted, unless the disclosure is made by the 
third party's authorized representative under the Energy Employees 
Occupational Illness Compensation Program Act (EEOICPA) program.
    (4) In general, information concerning a deceased third party may 
be disclosed; however, such information will be redacted if (a) the 
disclosure is made by an individual other than the survivor claimant, a 
parent, spouse, or child, or the authorized representative of the 
deceased third party; (b) if it is unclear whether the third party is 
living or deceased; or (c) the information is unrelated or irrelevant 
to the purpose of the disclosure.
    The Board will take reasonable steps to ensure that individuals 
making public comment are aware of the fact that their comments 
(including their name, if provided) will appear in a transcript of the 
meeting posted on a public Web site. Such reasonable steps include: (a) 
A statement read at the start of each public comment period stating 
that transcripts will be posted and names of speakers will not be 
redacted; (b) A printed copy of the statement mentioned in (a) above 
will be displayed on the table where individuals sign up to make public 
comments; (c) A statement such as outlined in (a) above will also 
appear with the agenda for a Board Meeting when it is posted on the 
NIOSH Web site; (d) A statement such as in (a) above will appear in the 
Federal Register Notice that announces Board and Subcommittee meetings.
    Contact Person For More Information: Theodore Katz, Designated 
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta, 
Georgia 30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO, 
email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-26757 Filed 10-20-15; 8:45 am]
BILLING CODE 4163-18-P